Glaxosmithkline Share News (GSK)

UK MORNING BRIEFING: William Hill Promotes From Within

PRESS: Investigator Says Glaxo Bribery Allegations In China "Credible"- BBC

UK Dividends Calendar - Week Ahead

MEDIA-Systematic bribery at GlaxoSmithKline China 'credible' - BBC

-- Source link: (http://bbc.in/1jOnuzT) -- Note: Reuters has not verified this story and does not vouch for its accuracy

UK Dividends Calendar - Week Ahead

Glaxo, Genmab Get EC Marketing Authorization For New Indication For Use Of Arzerra

China to try GSK-linked investigator in secret - family friends

SHANGHAI, July 3 (Reuters) - The trial in China of a British corporate investigator and his American wife and business partner arrested a year ago after they did work for GlaxoSmithKline PLC will be closed to the public, two family friends with knowledge of the matter told Reuters Thursday. Read more

MEDIA-China to try GSK couple 'in secret' - the Financial Times

-- Source link: (http://on.ft.com/TPuh5F) -- Note: Reuters has not verified this story and does not vouch for its accuracy

Roche biotech drug offers new way to fight asthma

LONDON, July 2 (Reuters) - An experimental antibody drug from Roche has produced promising results in mid-stage tests for asthma, offering a new way to fight the breathing disorder. The encouraging response seen with quilizumab, which the Swiss group is developing as a treatment for moderat

eg solutions Chief trades in 1.21m shares

Elizabeth Gooch, the acting Chief Executive Officer of eg solutions has traded in a total of 1.21m shares at 52p each, the software company said on Wednesday. Of these, 120,000 were acquired by the company's former Chairman, Rodney Baker-Bates, and a further 60,000 by Mark Brady, a non-executive d

Isis Pharma Earns USD1 Million From Glaxo For Advancing Hepatitis B Virus Program

ALLNEWSBLOG: One Year On - Alliance News By The Numbers

UPDATE 1-Cameron enlists ex-Goldman economist in global superbug fight

* Antimicrobial resistance discussed at recent G7 summit * Cameron warns of return to "dark ages" in medicine * Economist Jim O'Neill to head new antibiotics panel * Move welcomed by World Health Organisation head (Updates with details on timing of review, WHO reaction)

Wednesday broker round-up UPDATE

Anite: Investec places its target price (prev.: 88p) under review, while its hold recommendation remains unchanged. Ashcourt Rowan: N+1 Singer moves target price from 231p to 242p and keeps a buy recommendation. BG Group: Canaccord Genuity raises target price from 1250p to 1450p upgrading from hol

UK BROKER RATINGS: Numis Says Buy Schroders, Add St James's Place